E76.1
BillableMucopolysaccharidosis, type II
HCC Category Mapping
What This Code Means
Mucopolysaccharidosis type II, also known as Hunter syndrome, is an inherited disorder where the body accumulates complex sugars in cells, causing progressive damage to organs, bones, and the nervous system.
Coding Tips
- •MPS II is X-linked recessive; document whether the patient is a carrier, affected male, or affected female
- •Specify the severity (mild, moderate, or severe) if documented, as this affects management and prognosis
Clinical Significance
Mucopolysaccharidosis type II (Hunter syndrome) is an X-linked recessive lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase, leading to accumulation of dermatan and heparan sulfate. It primarily affects males and ranges from severe (with neurodegeneration) to attenuated forms, requiring enzyme replacement therapy and multidisciplinary care.
Documentation Requirements
- ✓Specific diagnosis of MPS II (Hunter syndrome) documented by provider
- ✓Confirmatory enzyme assay showing iduronate-2-sulfatase deficiency or IDS gene mutation analysis
- ✓Disease severity classification (severe/neuronopathic vs. attenuated/non-neuronopathic)
- ✓Current manifestations: coarse facial features, hepatosplenomegaly, cardiac involvement, skeletal abnormalities, airway obstruction
- ✓Treatment status: enzyme replacement therapy (idursulfase/Elaprase), intrathecal therapy, or supportive care